Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE1
43 participants
INTERVENTIONAL
2006-01-31
2009-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The purpose of this study is to examine 1) the feasibility of adapting cardiac rehabilitation for individuals with stroke, and 2) the effects of this program on aerobic capacity, walking, risk factors, community integration and quality of life.
The investigators anticipate that cardiac rehabilitation may be appropriately adapted to accommodate individuals with stroke who have a range of functional abilities, and that this program is effective in improving aerobic capacity, walking ability and stroke risk factors. The investigators also anticipate participants will demonstrate improved community integration and quality of life following this program.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cardiac Rehabilitation for TIA Patients
NCT00536562
Comparison of Traditional, Web-based or a Combined Cardiac Rehabilitation Programme
NCT05326529
Efficacy of Cardio-Oncology Rehabilitation Exercise for Women With Breast Cancer and Treatment Related Cardiotoxicity
NCT03089502
Effects of Cardiac Rehabilitation for Individuals With Transient Ischemic Attack
NCT00929994
Cardiac Rehabilitation Peer Mentorship
NCT02204449
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The main research question is: What is the feasibility and effect of cardiac rehabilitation in individuals following stroke?
The objectives are:
1. To determine if stroke survivors are able and willing to participate in a cardiac rehabilitation program. Specifically, to determine the feasibility of the cardiac rehabilitation program in individuals following stroke as determined by compliance to attendance and training requirements.
2. To determine if a cardiac rehabilitation program will have a meaningful benefit, among chronic stroke survivors, on:
* walking capacity and ability: considering functional capacity \[endurance / distance\] and quality \[neuromotor control\],
* community integration: considering quantity \[activity monitors\] and quality \[index of reintegration to normal living\] of activity
* health-related quality of life: as determined by stroke specific index
* risk factors for subsequent stroke: including exercise capacity, blood pressure, blood lipid profile
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Exercise
Cardiac rehabilitation
Participants will participate in a 6-month cardiac rehabilitation exercise program. This program will include aerobic and resistance training, and education sessions on risk factor management.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cardiac rehabilitation
Participants will participate in a 6-month cardiac rehabilitation exercise program. This program will include aerobic and resistance training, and education sessions on risk factor management.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* At least 3 months post-stroke
* Ability to understand the process and instructions for exercise training and provide informed consent
* Ability to complete 6-minute walk test
Exclusion Criteria
* Other cardiovascular morbidity which would limit exercise tolerance (heart failure, abnormal blood pressure responses or ST-segment depression \> 2 mm, symptomatic aortic stenosis, complex arrhythmias)
* Unstable angina
* Orthostatic blood pressure decrease of \> 20 mm Hg with symptoms
* Hypertrophic cardiomyopathy
* Other musculoskeletal impairments which would limit the participant's ability to cycle or walk
* Pain or other co-morbidities (e.g. unclipped aneurysms, uncontrolled seizures etc.) which would preclude participation
* Cognitive and/or behavioural issues that would limit participation in exercise testing and training
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Heart and Stroke Foundation of Ontario
OTHER
Toronto Rehabilitation Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Toronto Rehabilitation Institute
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
William E McIlroy, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Waterloo
Paul Oh, MD
Role: PRINCIPAL_INVESTIGATOR
Toronto Rehabilitation Institute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Toronto Rehabilitation Institute Cardiac Rehabilitation and Secondary Prevention Program - Rumsey Centre
Toronto, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Tang A, Marzolini S, Oh P, McIlroy WE, Brooks D. Feasibility and effects of adapted cardiac rehabilitation after stroke: a prospective trial. BMC Neurol. 2010 Jun 9;10:40. doi: 10.1186/1471-2377-10-40.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HSFO-SRA5977
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.